Vireo Growth (VREOF) Asset Writedowns and Impairment (2022 - 2026)

Vireo Growth (VREOF) reported Asset Writedowns and Impairment of $300000.0 for Q1 2026, down 25.0% on a YoY basis from $400000.0 in Q1 2025, and down 86.88% sequentially from $2.3 million in Q4 2025.

Vireo Growth (VREOF) Asset Writedowns and Impairment (2022 - 2026) Analysis & Trends

Vireo Growth (VREOF) has 4 years of Asset Writedowns and Impairment data on file, last reported at $300000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Asset Writedowns and Impairment fell 25.0% year-over-year to $300000.0; the trailing twelve-month figure through Mar 2026 stood at $3.4 million (up 274.14% YoY), and the FY2025 full-year result was $2.6 million, up 784.35% from the prior year.
  • Asset Writedowns and Impairment declined to $300000.0 in Q1 2026, from $2.3 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $5.3 million in Q1 2022 to a low of -$304000.0 in Q1 2024.
  • A 4-year average of $965084.7 and a median of $393000.0 in 2024 frame the typical range for Asset Writedowns and Impairment.
  • Peak annual rise in Asset Writedowns and Impairment reached 3518.72% in 2025, while the deepest fall reached 651.58% in 2025.
  • Tracing VREOF's Asset Writedowns and Impairment over 4 years: stood at $1.1 million in 2022, then plunged by 94.36% to $63182.0 in 2024, then surged by 3518.72% to $2.3 million in 2025, then slumped by 86.88% to $300000.0 in 2026.
  • Business Quant data shows VREOF's Asset Writedowns and Impairment at $300000.0 in Q1 2026, $2.3 million in Q4 2025, and $996485.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 300,000.00
Mar 31, 2026 300,000.00
Dec 31, 2025 2.29 Mn
Dec 31, 2025 2.29 Mn
Sep 30, 2025 996,485.00
Sep 30, 2025 996,485.00
Jun 30, 2025 -226,149.00
Jun 30, 2025 -226,149.00
Mar 31, 2025 400,000.00
Mar 31, 2025 400,000.00
Dec 31, 2024 63,182.00
Dec 31, 2024 63,182.00
Sep 30, 2024 393,000.00
Sep 30, 2024 393,000.00
Jun 30, 2024 41,000.00
Jun 30, 2024 41,000.00
Mar 31, 2024 -304,000.00
Mar 31, 2024 -304,000.00
Dec 31, 2022 1.12 Mn
Dec 31, 2022 1.12 Mn